STOCKHOLM, SE / ACCESSWIRE / October 10, 2024 / (STO:ALZCUR) (FRA:AC6) AB (publ) (FN STO: ALZCUR), a pharmaceutical company ...

Lyka Labs shares rose as the company announced that it has received the CDSCO approval for manufacturing & marketing of of ...

ACD440 is a first-in-class TRPV1 antagonist in clinical phase being developed as a new topical local treatment for peripheral neuropathic pain. The drug candidate, which was incorporated via ...

The heterogeneous nature of the mechanisms underlying neuropathic pain complicates the selection of appropriate treatments for individual patients. Although systematic reviews have outlined the ...

Burning mouth syndrome results in pain on one or both sides of the tongue. Learn how to manage oral symptoms and get to a ...

In the 24-week, phase 3 DELTA FORCE trial, topical ... treatment success (defined as a score of 0/1 indicating clear/almost clear skin), changes in Hand Eczema Symptom Diary (HESD) itch and HESD ...

Among the various treatment options available for osteoarthritis, topical creams, and gels have gained popularity. These medications are applied directly to the affected area, offering pain relief ...

If you have early climax (PE), you may have heard that selective serotonin reuptake inhibitors (SSRIs) and topical creams and ...

For clinicians on the challenging front line of chronic pain treatment, the tale of a general ... He has used this technique with people experiencing neuropathic pain, which arises from nerve ...

ZTlido ® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. GLOPERBA ® is the subject of an exclusive, transferable license to Scilex ...